Intron's net debt increased to CNY 990 million by December 2023 from CNY 60 million at the end of 2021. The company has typical trade payables settlement times (around 60 days) that are shorter ...

Researchers Shed Light On Intron Evolution Date: December 27, 2004 Source: Massachusetts Institute Of Technology Summary: By comparing four fungal genomes, researchers from MIT and the Broad ...

Intron Technology’s 01760 2022 result was driven by strong growth in revenue from electric vehicles and automated vehicles, with consolidated revenue up 52% and net profit up 107%. Together ...

iNtRON Grants Basilea exclusive right for preclinical evaluation with an undisclosed payment Basilea has the option to enter into exclusive License Agreement following the evaluation BOSTON and ...

Intron Biotechnology Inc. has announced the identification of lysogenic bacteriophages prophage and jamphage in the pancreatic cancer-related microbiome. This identification was achieved as part of ...

The authors also identified, in an individual of Moroccan ancestry, a related variant present at very low frequency in gnomAD (0.0004062 percent), and involving a deletion of two nucleotides in the ...

Complete Intron Technology Holdings Ltd. stock information by Barron's. View real-time 1760 stock price and news, along with industry-best analysis.

iNtRON Biotechnology, Inc., a biotechnology company focused on developing innovative endolysin-based new biological drug for superbugs and unmet medical needs, today announced the strategic ...